vero

  1. T

    Baxter And Takeda Complete Agreement For Vero Cell-Based Influenza Vaccines In Japan

    Deerfield, Ill., USA, and Osaka and Tokyo, Japan, December 02, 2010 - Baxter International Inc. (Headquarters: Illinois, USA) ("Baxter") and Takeda Pharmaceutical Company Limited (Headquarters: Osaka, Japan) ("Takeda") today announced that the parties have completed a Development, License and...
Back
Top